ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
BioLineRx Ltd

BioLineRx Ltd (BLRX)

3,33
-0,16
(-4,58%)
Geschlossen 08 Februar 10:00PM
3,477
0,147
(4,41%)
Nach Börsenschluss: 1:55AM

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

Current Price
3,477
Gebot
3,32
Fragen
3,47
Volumen
141.184
3,26 Tagesbereich 3,49
0,00 52-Wochen-Bereich 0,00
Marktkapitalisierung
Handelsende
3,49
Handelsbeginn
3,46
Letzte Trade
41
@
3.36
Letzter Handelszeitpunkt
Finanzvolumen
US$ 472.745
VWAP
3,3484
Durchschnittliches Volumen (3 Mio.)
-
Ausgegebene Aktien
3.558.503
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
0,00
Gewinn pro Aktie (EPS)
-
Erlöse
4,8M
Nettogewinn
-60,61M

Über BioLineRx Ltd

BioLine Rx Ltd is a clinical-stage biopharmaceutical development company with a strategic focus on oncology. Its development and commercialization pipeline consists of two clinical-stage therapeutic candidates - Motixafortide, a novel peptide for the treatment of solid tumors, hematological malignan... BioLine Rx Ltd is a clinical-stage biopharmaceutical development company with a strategic focus on oncology. Its development and commercialization pipeline consists of two clinical-stage therapeutic candidates - Motixafortide, a novel peptide for the treatment of solid tumors, hematological malignancies and stem cell mobilization, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, it has an off- strategy, a legacy therapeutic product called BL-5010 for the treatment of skin lesions. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Coml Physical, Biologcl Resh
Hauptsitz
Modi'in-maccabim-re'ut, Center, Isr
Gegründet
2011
BioLineRx Ltd is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker BLRX. The last closing price for BioLineRx was US$3,49. Over the last year, BioLineRx shares have traded in a share price range of US$ 0,00 to US$ 0,00.

BioLineRx currently has 3.558.503 shares in issue. The market capitalisation of BioLineRx is US$12,42 million.

BLRX Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

BLRX - Frequently Asked Questions (FAQ)

What is the current BioLineRx share price?
The current share price of BioLineRx is US$ 3,477
How many BioLineRx shares are in issue?
BioLineRx has 3.558.503 shares in issue
What is the market cap of BioLineRx?
The market capitalisation of BioLineRx is USD 12,42M
What is the 1 year trading range for BioLineRx share price?
BioLineRx has traded in the range of US$ 0,00 to US$ 0,00 during the past year
What is the reporting currency for BioLineRx?
BioLineRx reports financial results in USD
What is the latest annual turnover for BioLineRx?
The latest annual turnover of BioLineRx is USD 4,8M
What is the latest annual profit for BioLineRx?
The latest annual profit of BioLineRx is USD -60,61M
What is the registered address of BioLineRx?
The registered address for BioLineRx is MODI’IN TECHNOLOGY PARK, 2 HAMA’AYAN STREET, MODI’IN, MODI'IN-MACCABIM-RE'UT, CENTER, 7177871
What is the BioLineRx website address?
The website address for BioLineRx is www.biolinerx.com
Which industry sector does BioLineRx operate in?
BioLineRx operates in the COML PHYSICAL, BIOLOGCL RESH sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
MGOLMGO Global Inc
US$ 0,4191
(126,54%)
816,59M
CDTConduit Pharmaceuticals Inc
US$ 2,831
(82,65%)
144,17M
GSIWGarden Stage Ltd
US$ 0,79
(78,73%)
219,64M
TOIIWOncology Institute Inc
US$ 0,033
(58,88%)
7,27k
CYTHCyclo Therapeutics Inc
US$ 1,19
(54,55%)
84,73M
FTELFitell Corporation
US$ 2,70
(-57,01%)
2,28M
SGBXSafe and Green Holdings Corporation
US$ 0,6401
(-44,82%)
5,15M
NKLANikola Corporation
US$ 0,4432
(-41,10%)
47,43M
PLRXPliant Therapeutics Inc
US$ 7,785
(-34,85%)
6,4M
LIPOLipella Pharmaceuticals Inc
US$ 3,08
(-33,76%)
2,08M
MGOLMGO Global Inc
US$ 0,4191
(126,54%)
780,46M
RIMEAlgorhythm Holdings Inc
US$ 0,0169
(-20,66%)
262,79M
GSIWGarden Stage Ltd
US$ 0,79
(78,73%)
215,16M
BHATBlue Hat Interactive Entertainment Technology
US$ 0,0537
(14,74%)
210,78M
NVDANVIDIA Corporation
US$ 129,84
(0,90%)
209,04M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock